Author:
Zhang Like,Jiang Xia,Wang Guiqi,Kanda Tatsuo,Yokosuka Osamu,Zhai Congjie,Zhang Lei,Liu Peng,Zhao Zengren,Li Zhongxin
Abstract
Abstract
Background
The most common type of cancer of the digestive system is hepatocellular carcinoma. In China, many patients harbour HBV. The lin28B/Let-7c/MYC axis is associated with the occurrence of many cancers. Therefore, we aimed to illuminate the function of the lin28B/Let-7c/MYC axis in hepatocellular carcinoma. We aimed to evaluate the critical involvement of lin28B and Let-7c in the carcinogenesis of human hepatocellular carcinoma (B-HCC).
Methods
Data from the GEO database were used to analyse differentially expressed genes and IRGs. A protein − protein interaction (PPI) network and Venn diagram were generated to analyse relationships. Real-time RT-PCR, Western blotting, and cell counting kit-8 assays were used to examine the association of lin28B, Let-7c, and MYC with cell proliferation.
Results
A total of 2552 functionally annotated differentially expressed RNAs were analysed in HBV patients from the GSE135860 database. In addition, 46 let-7c target genes were screened in HBV patients, and the interactions were analysed through PPI network analysis. The results confirmed that Let-7c and its target genes play a key role in HBV-related diseases. Next, we discovered a gradual decrease in Let-7c expression during the progression from HBV-associated chronic hepatitis (B-CH) and HBV-associated liver cirrhosis (B-LC) to B-HCC. We found evidence for a negative association between lin28B expression and Let-7c expression. The expression of MYC was obviously upregulated when Let-7c was inhibited.
Conclusion
Our results highlight that Let-7c and lin28B participate in the carcinogenesis of HBV-associated diseases through the lin28B/Let-7c/MYC axis.
Funder
youth science and technology project of Hebei provincial health commission
the natural science foundation of Hebei
other foundation from Hebei province
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Infectious Diseases,Oncology,Epidemiology
Reference43 articles.
1. Chen W, Zheng R, Zeng H, et al. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015;27(1):2–12. https://doi.org/10.3978/j.issn.1000-9604.2015.01.06.
2. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. https://doi.org/10.3322/caac.21338.
3. Mcguire S. World cancer report 2014 geneva, Switzerland: World Health Organization, international agency for research on cancer WHO Press, 2015. Adv Nutr. 2016;2016(7):418–9. https://doi.org/10.3945/an.116.012211.
4. Arbuthnot P, Kew M. Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol. 2001;82(2):77–100. https://doi.org/10.1111/j.1365-2613.2001.iep0082-0077-x.
5. He Y, Xu Z, Tian G, et al. The mortality rate and disease burden of malignant tumors for the residents in hebei province. Chin J Health Stat. 2011;28(4):380–3.